Senseonics Holdings SENS
NASDAQ SENS
$9.71 +0.89 (+10.09%)
At close: Aug 21, 2026 · 4:00 PM EDT

Senseonics Holdings (SENS) Cash from Financing Activities (2014 - 2026)

Senseonics Holdings (SENS) posted quarterly Cash from Financing Activities of $3.4 million for Q1 2026, down 44.32% year-over-year from $6.1 million in Q1 2025, and up 210.29% quarter-over-quarter from $1.1 million in Q4 2025.

Senseonics Holdings (SENS) Cash from Financing Activities (2014 - 2026) Analysis & Trends

Senseonics Holdings (SENS) has reported Cash from Financing Activities for 13 consecutive years, with $3.4 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 44.32% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $75.5 million (up 229.37% YoY), while the FY2025 annual figure was $78.2 million, up 191.42% from the prior year.
  • Cash from Financing Activities advanced to $3.4 million in Q1 2026 per SENS's latest filing, from $1.1 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $71.1 million in Q2 2025 and bottomed at -$1.8 million in Q2 2022.
  • Historically, Cash from Financing Activities has averaged $10.0 million across 5 years, with a median of $5.5 million in 2023.
  • Annual changes were most pronounced in 2024 — Cash from Financing Activities sank 118.42% — and 2025, when it soared 7084.77%.
  • Senseonics Holdings' Cash from Financing Activities stood at $10.3 million in 2022, then tumbled by 111.39% to -$1.2 million in 2023, then soared by 1294.48% to $14.1 million in 2024, then sank by 92.2% to $1.1 million in 2025, then jumped by 210.29% to $3.4 million in 2026.
  • Business Quant data shows SENS's Cash from Financing Activities at $3.4 million in Q1 2026, $1.1 million in Q4 2025, and -$134000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -3.52 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -95.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -410.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -300,000.00
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -607.30 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -236.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -1.34 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -213.50 Mn
10 Senseonics Holdings 560.79 Mn 320.18 Mn 8.56 Mn 108.66 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 108.66 Mn
Jun 30, 2026 108.66 Mn
Mar 31, 2026 3.41 Mn
Mar 31, 2026 3.41 Mn
Dec 31, 2025 1.10 Mn
Dec 31, 2025 1.10 Mn
Sep 30, 2025 -134,000.00
Sep 30, 2025 -134,000.00
Jun 30, 2025 71.11 Mn
Jun 30, 2025 71.11 Mn
Mar 31, 2025 6.12 Mn
Mar 31, 2025 6.12 Mn
Dec 31, 2024 14.07 Mn
Dec 31, 2024 14.07 Mn
Sep 30, 2024 3.74 Mn
Sep 30, 2024 3.74 Mn
Jun 30, 2024 -1.02 Mn
Jun 30, 2024 -1.02 Mn
Mar 31, 2024 10.03 Mn
Mar 31, 2024 10.03 Mn